NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH
Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis
Similar Organizations
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Employees Featured
Elise Burmeister Getz
Elise Burmeister Getz Director, Translational Medicine @ Novartis Institutes for Biomedical Research Director, Translational Medicine 2021-03-01
Joris van Dam
Joris van Dam Executive Director, Head of Digital Therapeutics @ Novartis Institutes for Biomedical Research Executive Director, Head of Digital Therapeutics 2018-03-01
Jason Laramie
Jason Laramie Title Vice President, Global Head Translational Medicine Data Science @ Novartis Institutes for Biomedical Research Title Vice President, Global Head Translational Medicine Data Science 2019-04-01
Ross Jones
Ross Jones Lead of Product Excellence & Head of Product Operations @ Novartis Institutes for Biomedical Research Lead of Product Excellence & Head of Product Operations 2021-04-01
Reza Mazhari
Reza Mazhari Head, Search & Evaluation, Oncology @ Novartis Institutes for Biomedical Research Head, Search & Evaluation, Oncology 2018-07-01
Ann Richardson
Ann Richardson CEO @ Novartis Institutes for Biomedical Research CEO
Wendi Yajnik
Wendi Yajnik Global Head of Academic Partnerships and External Innovation @ Novartis Institutes for Biomedical Research Global Head of Academic Partnerships and External Innovation 2018-04-01
Elizabeth Mazsa
Elizabeth Mazsa CS&I Academy Fellow @ Novartis Institutes for Biomedical Research CS&I Academy Fellow 2021-01-01
Thomas Jostock
Thomas Jostock Associate Director @ Novartis Institutes for Biomedical Research Associate Director 2020-03-01
Philip Gotwals
Philip Gotwals Global Head, Business Development & Licensing @ Novartis Institutes for Biomedical Research Global Head, Business Development & Licensing 2019-11-01
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-02-24 | Orna Therapeutics | Novartis Institutes for Biomedical Research investment in Series A - Orna Therapeutics | 80 M USD |
2020-04-29 | Cadent Therapeutics | Novartis Institutes for Biomedical Research investment in Series B - Cadent Therapeutics | 15 M USD |
2020-03-03 | Pliant Therapeutics | Novartis Institutes for Biomedical Research investment in Series C - Pliant Therapeutics | 100.45 M USD |
2020-01-10 | TScan Therapeutics | Novartis Institutes for Biomedical Research investment in Series B - TScan Therapeutics | 35 M USD |
2019-07-24 | TScan Therapeutics | Novartis Institutes for Biomedical Research investment in Series B - TScan Therapeutics | N/A |
2019-02-14 | Vor Biopharma | Novartis Institutes for Biomedical Research investment in Series A - Vor Biopharma | 42 M USD |
2018-11-15 | Cadent Therapeutics | Novartis Institutes for Biomedical Research investment in Series B - Cadent Therapeutics | 40 M USD |
2015-01-08 | Surface Oncology | Novartis Institutes for Biomedical Research investment in Series A - Surface Oncology | 35 M USD |